FDA Inspection 1193404 — Ana Boban, M.D.
The FDA completed an inspection of Ana Boban, M.D. on December 8, 2022 in Zagreb. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 8, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Zagreb (Croatia)
Additional Details
Clinical Investigator (CI)